SCHEMBL16854613

SCHEMBL16854613

CCCCOC(COC(c1ccccc1)(c1ccccc1)c1ccccc1)COS(C)(=O)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 6/20 0.50
PLA2G10 O15496 4/20 0.50
PLA2G1B P04054 3/20 0.50
PLA2G5 P39877 3/20 0.50
KIF11 P52732 1/20 0.35
ALDH1A1 P00352 3/20 0.33
HDAC6 Q9UBN7 2/20 0.33
TSHR P16473 2/20 0.33
HPGD P15428 1/20 0.33
TK1 P04183 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
TK2 O00142 1/20 0.32
PPARD Q03181 1/20 0.32
LTA4H P09960 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18912718 0.88 PLA2G2A (0.55) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL8357825 0.83 PLA2G2A (0.59) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL16826862 0.82 CA1 (0.36) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL8979451 0.80 PLA2G2A (0.54) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL18609340 0.80 PLA2G2A (0.49) PLA2G2APLA2G10PLA2G1BPLA2G5KIF11
SCHEMBL8357808 0.80 PLA2G2A (0.49) PLA2G2APLA2G10PLA2G1BPLA2G5TK1
SCHEMBL8352756 0.80 PLA2G2A (0.49) PLA2G2APLA2G10PLA2G1BPLA2G5TK1
SCHEMBL8353085 0.80 PLA2G2A (0.49) PLA2G2APLA2G10PLA2G1BPLA2G5TK1
SCHEMBL8741371 0.80 PLA2G2A (0.49) PLA2G2APLA2G10PLA2G1BPLA2G5TK1
SCHEMBL8193378 0.80 PLA2G2A (0.49) PLA2G2APLA2G10PLA2G1BPLA2G5TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170066782-A1 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5-AMINE NEKTAR THERAPEUTICS 2017-03-09 US disclosed
WO-2015092819-A2 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5- AMINE NEKTAR THERAPEUTICS (INDIA) PVT. LTD. (IN) 2015-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170066782-A1 DERIVATIVES OF 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZIN-5-AMINE KCNJ2, TRPC5, RYR2 PLA2G2A 3284/4885PLA2G10 3651/4885PLA2G1B 3066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.